Novo Nordisk A/S buy shivbud
Start price
03.09.23
/
0%
€176.50
Target price
03.09.24
-
Performance (%)
5.34%
Price
12.09.23
€185.00
Summary
This prediction is currently active. With a performance of 5.34%, the BUY prediction by shivbud for Novo Nordisk A/S is trending in the right direction. A total of €0.93 was paid as dividends for this prediction. This prediction currently runs until 03.09.24. The prediction end date can be changed by shivbud at any time. This prediction was marked as speculative and is excluded from shivbud's performance statistics.Novo Nordisk is a Danish pharmaceutical company that specializes in diabetes care and research. It is considered to be one of the largest companies in the world that focus exclusively on diabetes management, with a product portfolio that ranges from insulin treatment to obesity management. The company is listed on the Copenhagen Stock Exchange and has gained global recognition for its commitment to sustainable business practices and its contribution to diabetes research and treatment. Novo Nordisk has a strong financial track record and has consistently delivered solid returns to investors over the years.
Performance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Novo Nordisk A/S | - | - |
| iShares Core DAX® | 2.831% | 1.236% |
| iShares Nasdaq 100 | 2.918% | 0.640% |
| iShares Nikkei 225® | 2.007% | -2.135% |
| iShares S&P 500 | 2.257% | 0.451% |
Comments by shivbud for this prediction
In the thread Novo Nordisk A/S diskutieren
Buy Novo Nordisk A/S